ECSP21078755A - Composición para regeneración de tejidos, método de producción y usos de la misma - Google Patents

Composición para regeneración de tejidos, método de producción y usos de la misma

Info

Publication number
ECSP21078755A
ECSP21078755A ECSENADI202178755A ECDI202178755A ECSP21078755A EC SP21078755 A ECSP21078755 A EC SP21078755A EC SENADI202178755 A ECSENADI202178755 A EC SENADI202178755A EC DI202178755 A ECDI202178755 A EC DI202178755A EC SP21078755 A ECSP21078755 A EC SP21078755A
Authority
EC
Ecuador
Prior art keywords
tissue
compositions
specific
composition
macrophages
Prior art date
Application number
ECSENADI202178755A
Other languages
English (en)
Inventor
Vicente Pablo Fernández
Gregorio Juan Carlos De
Moreno Jara Sanz
Martínez Alejandro Blázquez
Cepa Gonzalo Gómez
Anjos Vilaboa Severiano Dos
Calvo María Cayuela
Moreno Carmen Iglesias
Fernández Juan Pedro Lapuente
Bielsa Paula Desporte
Original Assignee
Peaches S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peaches S L filed Critical Peaches S L
Publication of ECSP21078755A publication Critical patent/ECSP21078755A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/99—Serum-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/08—Coculture with; Conditioned medium produced by cells of the nervous system
    • C12N2502/086—Coculture with; Conditioned medium produced by cells of the nervous system glial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C12N2502/1157—Monocytes, macrophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1317—Chondrocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1335—Skeletal muscle cells, myocytes, myoblasts, myotubes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1341—Tenocytes, cells from tendons and ligaments
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1352—Mesenchymal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
    • C12N2506/115—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells from monocytes, from macrophages

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)

Abstract

La invención describe un método para obtener una composición para regeneración de tejido, que comprende los siguientes pasos: proporcionar macrófagos M2, cocultivar los macrófagos M2 con células específicas de tejido en medio libre de suero; y recolectar el sobrenadante del cocultivo. Las composiciones obtenidas por este método son adecuadas en tratamientos regenerativos medicinales, ya que son capaces de regenerar el tejido lesionado. Estos productos son soluciones acuosas fisiológicas estériles sin células que muestran patrones de concentración de tejido específicos para proporcionar efectos regenerativos específicos de tejido óptimos. Las composiciones de la invención pueden almacenar por periodos prolongados crioconservados o liofilizados hasta su uso, evitando cualquier extracción de sangre subsecuente del donante de células, que son los factores de crecimiento y/o citocinas almacenados biológicamente activas después almacenamiento a largo plazo. Por otra, las composiciones se pueden aplicar potencialmente en tratamientos tanto autólogos como alogénicos.
ECSENADI202178755A 2019-04-03 2021-11-11 Composición para regeneración de tejidos, método de producción y usos de la misma ECSP21078755A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19382247.5A EP3719119B8 (en) 2019-04-03 2019-04-03 Tissue-specific growth factors, method of production and uses thereof

Publications (1)

Publication Number Publication Date
ECSP21078755A true ECSP21078755A (es) 2021-12-30

Family

ID=66240019

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202178755A ECSP21078755A (es) 2019-04-03 2021-11-11 Composición para regeneración de tejidos, método de producción y usos de la misma

Country Status (20)

Country Link
US (1) US20220169987A1 (es)
EP (2) EP3719119B8 (es)
CN (1) CN113825833A (es)
AU (1) AU2020252248B2 (es)
BR (1) BR112021019745A2 (es)
CA (1) CA3135661A1 (es)
CL (1) CL2021002567A1 (es)
CO (1) CO2021014689A2 (es)
CR (1) CR20210549A (es)
DO (1) DOP2021000207A (es)
EC (1) ECSP21078755A (es)
ES (2) ES3009758T3 (es)
HR (1) HRP20240153T1 (es)
HU (1) HUE065101T2 (es)
MX (1) MX2021012141A (es)
PE (1) PE20220424A1 (es)
PL (1) PL3947648T3 (es)
PT (1) PT3719119T (es)
RS (1) RS65119B1 (es)
WO (1) WO2020201404A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12285636B2 (en) 2021-08-05 2025-04-29 The University Of Washington Non-planar holographic beam shaping lenses for acoustics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9950035B2 (en) * 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
TWI640631B (zh) * 2017-08-16 2018-11-11 國立屏東科技大學 Macrophage conditioned medium, dressing, preparation method and use thereof for promoting wound healing

Also Published As

Publication number Publication date
PE20220424A1 (es) 2022-03-29
ES2971499T3 (es) 2024-06-05
CL2021002567A1 (es) 2022-06-17
HRP20240153T1 (hr) 2024-04-26
PL3947648T3 (pl) 2024-04-15
BR112021019745A2 (pt) 2021-12-21
EP3719119A1 (en) 2020-10-07
EP3719119B1 (en) 2024-11-13
RS65119B1 (sr) 2024-02-29
HUE065101T2 (hu) 2024-05-28
EP3947648C0 (en) 2023-11-15
EP3947648B1 (en) 2023-11-15
PT3719119T (pt) 2024-12-18
AU2020252248A1 (en) 2021-11-25
US20220169987A1 (en) 2022-06-02
ES3009758T3 (en) 2025-03-31
DOP2021000207A (es) 2021-11-21
EP3719119B8 (en) 2026-02-18
MX2021012141A (es) 2021-11-03
EP3947648A1 (en) 2022-02-09
CR20210549A (es) 2021-11-30
CN113825833A (zh) 2021-12-21
WO2020201404A1 (en) 2020-10-08
AU2020252248B2 (en) 2026-03-26
CA3135661A1 (en) 2020-10-08
EP3719119C0 (en) 2024-11-13
CO2021014689A2 (es) 2021-11-19

Similar Documents

Publication Publication Date Title
MX352745B (es) Soluciones estabilizadas de acido hipohaloso.
MX2018002038A (es) Formulaciones clinicas.
MX2018009551A (es) Estructuras descelularizadas de la pared celular de plantas y hongos y uso de las mismas como materiales de andamio.
ES2749178T3 (es) Matrices de tejido funcionalizado
AR068850A1 (es) Soluciones de dialisis que contienen pirofosfatos
JP2016520068A5 (es)
AR118238A1 (es) Implantes de cabello que comprenden características mejoradas de fijación y seguridad médica
EP4331842A3 (en) Three-dimensional lattice structures for implants
AR080219A1 (es) Productos de membranas corionicas inmunocompatibles
ES2721898T3 (es) Formulaciones estables para liofilizar partículas terapéuticas
CL2021001141A1 (es) Composiciones para el tratamiento de biopelículas sin inducir resistencia antimicrobiana
DOP2012000030A (es) Polipéptidos del factor ix modificados y usos de los mismos
ES2993384T3 (en) Sterile human placental allografts and methods of making thereof
Park et al. Updating on understanding and managing chronic wound
ECSP21078755A (es) Composición para regeneración de tejidos, método de producción y usos de la misma
AR099556A1 (es) Implante que contiene fgf-18
BR112021020141A2 (pt) Combinação de chir99021 e ácido valpróico para tratamento de perda auditiva
BR112023018291A2 (pt) Implante de reconstrução mamária
CO2021013328A2 (es) Implantes de cabello que comprenden características mejoradas de fijación y seguridad médica
WO2020230997A3 (ko) 유두-유륜 복합체 재건용 임플란트 및 이의 제조방법
ES2964142T3 (es) Procedimiento de obtención de un tejido dermoepidérmico prevascularizado
MX2020000024A (es) Parche para la regeneracion de tejidos biologicos y procedimiento de fabricacion del mismo.
AR083006A1 (es) Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
CL2025003358A1 (es) Composiciones potenciadoras de perácido y métodos para su uso.
PEI et al. Current application of concentrated growth factors in periodontal tissue regeneration